Screening for lung cancer with a blood test
Part of Cancer, Lungs & breathing clinical trials.
This study is testing a new blood test that looks for signs of lung cancer in your blood platelets. If you have a lung nodule that needs further testing or have been diagnosed with lung cancer, this test might help doctors find cancer earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years old or older
- You have a lung nodule seen on a CT scan or other chest image in the last 6 months that needs a biopsy, surgery, or other procedure, or you have been diagnosed with lung cancer
- You have not been treated for any other cancer (except certain minor skin, cervical, or low-risk prostate cancers) in the last 6 months
- You have not had lung cancer surgery or any treatment for lung cancer in the past 2 years
- You are not currently receiving chemotherapy, immunotherapy, targeted therapy, or radiation for lung cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
This trial uses a simple blood test to look at certain genetic markers that may help doctors decide if a lung nodule is cancerous or not. It is designed for people who have a lung nodule that needs further testing like a biopsy or surgery.
This study looks at whether a new test can better identify early lung cancer in people who are being watched for an incidental lung nodule. It may help doctors decide which nodules need closer follow-up or treatment.
This trial uses a new, non-invasive way to screen for lung cancer by combining your breath, blood, and CT scan images. The goal is to figure out whether a nodule found on a CT scan is cancerous or not, which could help patients avoid unnecessary procedures.
This study looks at whether MRI scans and blood-related biomarkers can help better understand lung nodules found during routine lung cancer screening. It may help doctors decide which nodules need closer follow-up versus less intensive monitoring.
This study aims to see if a blood test can tell if a lung nodule is cancerous or not. It may help doctors avoid unnecessary procedures.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.